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On January 4, 2020, the World Health Organization (WHO)
tweeted1:
#China has reported to WHO a cluster of #pneumonia
cases dwith no deathsd in Wuhan, Hubei Province.
Investigations are underway to identify the cause of this
illness.
The etiology of the pneumonia referred to was subse-
quently identified as SARS-CoV-2, the novel virus causing
COVID-19. COVID-19 swept across the globe, and the
WHO characterized it as a pandemic on March 11.1 In its
wake, oncologists were faced with multiple challenges and
few resources to help navigate new clinical realities. Who is
most at risk for COVID-19? Should cancer treatment
continue or be delayed? How should radiation oncology
proceed?
National and international professional societies pub-
lished detailed clinical guidance, including American So-
ciety of Radiation Oncology (ASTRO), American Society
of Clinical Oncology (ASCO), and European Society for
Radiotherapy and Oncology (ESTRO), among others.
These recommendations were unique in the rapid fashion in
which they were created and shared. The guidance offered
was broad because its application was highly dependent on
the specific location of the patient and radiation facility. For
example, in the United States, locales within New York and
New Jersey were overwhelmed with coronavirus cases
while other states had relatively few cases.2
The ASTRO web team was extremely nimble as lead-
ership and staff created content related to COVID-19. A
new section of the website in the daily practice tab was
added in March 2020 to house the rapidly evolving content.
As new content was submitted, the section was reorganized
for easy navigation. Overall, this section has had 58,961
page views as of June 12, 2020. The most frequently visited
pages were summary (17,548 views), FAQs (14,603 views),
and journal articles (11,579 views).
Social media are defined as interactive forms of elec-
tronic communication.3 During the COVID-19 epidemic,
these tools were used by the radiation oncology community
to connect and share information. Platforms including
Twitter, Facebook, Instagram, WhatsApp, ASTRO ROHub,
webinars, and podcasts were used to disseminate experi-
ences and foster communication among oncologists
worldwide. In this brief report, we share some examples of
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how social media filled a strong need for information-
sharing during the crisis.
Twitter
Twitter is a microblogging platform in which users can
share sentences (otherwise known as tweets) of up to 280
characters. During the pandemic, oncologists from all over
the world shared their experiences caring for patients dur-
ing this difficult time. Practical information was exchanged,
including patient scheduling, initiating telemedicine, per-
sonal protection equipment (PPE) use, on-treatment visits,
remote work, SARS-CoV-2 testing procedures, and
research publications. Twitter was also used by ASTRO’s
journals to disseminate links to preprints of new COVID-19
research.4 Group messaging via Twitter was also used to
share tweets and information globally. For example, the
OncoAlert COVID-19 group messaging includes oncolo-
gists from the United States, United Kingdom, Sweden,
Italy, and many other countries. Information from Europe
was shared with members of this group (including author
M.K.) before the COVID-19 surge in the United States.
Tweets regarding how European oncologists were handling
the crisis (managing COVID-19epositive patients, hospi-
tals bed shortages, and cancer care continuation) helped
US-based oncologists understand and prepare for the
challenges coming their way via the US surge from
COVID-19. Figure 1 shows a Twitter poll created by author
M.K. asking the question: “Oncologists: Has social media
helped you navigate the #coronavirus pandemic more
successfully?” Sixty 6% responded “yes,” and 15%
responded “unsure.”
Group Messaging: Facebook and WhatsApp
The number of Facebook groups for physicians has
exploded during the past 5 years and is often organized
according to member interests within medicine (ie, spe-
cialty, as in interventional radiology interest groups) or
outside medicine (eg, motherhood, as in physician moms’
groups).5 The COVID-19 physician group was created on
March 12, 2020, for physicians and is described on its
Facebook group page as “An inclusive resource for physi-
cians to share front line clinical information about COVID-
19 as it becomes available.”6 Of note, the group was started
before the US coronavirus surge but quickly grew because
physicians understood the importance of gaining knowl-
edge from their peers. As of June 1, 2020, the group had
28,287 members. There were 578 new posts in May 2020.
The administrators and moderators of the group instruct
members to share clinical information only and to provide
references and links to articles. Many COVID-19erelated
posts were also shared on the radiation oncology women’s
Facebook group page and on the hematology oncology
women’s Facebook group page.
Many of the clinical features of COVID-19 came to be
identified by physicians who communicated with each
other remotely during the initial phases of the pandemic,
including the dermatologic “COVID toes,” anosmia, and
hypercoagulability. The crowdsourcing of information
across groups via Facebook, WhatsApp, and others allowed
for quick dissemination of knowledge. Authors M.K. and
A.D. participated in a WhatsApp global group of radiation
oncologists, in which resources were quickly shared. For
example, a webinar presented at Jefferson regarding how to
identify COVID-19 from computed tomography scans was
recorded via Zoom and uploaded to DropBox. The Drop-
Box link was then shared to the WhatsApp group. Another
resource shared across messaging platforms was a Google
Docs spreadsheet created by trainees, which listed radiation
oncology programs and the residents’ roles and re-
sponsibilities during COVID-19, such as if trainees worked
from home.
ASTRO’s ROhub
ROhub is an online forum hosted by ASTRO where
members can discuss radiation oncology topics. During the
coronavirus pandemic, many individuals shared questions,
information, and ideas about radiation oncologists’ expe-
riences with COVID-19. In particular, physician experi-
ences from COVID-19 epicenters in New York City and
New Jersey proved to be extremely helpful. These topics
included the American Board of Radiology examinations,
interviews, COVID-19 testing, telemedicine, provider relief
funds, and much more. The online forum provided a unique
space for ASTRO members to exchange ideasdarguably a
space that does not exist elsewhere.
Membership engagement with the ROhub has grown
considerably during the past year, especially in the open
forum, member directory, and event communities. Per
communication from ASTRO, in 2020 the open forum so
far has had 154,828 views and the member directory has
had 63,762 views.
The open forum has been a dynamic communication
vehicle during the COVID-19 outbreak. Members and staff
Fig. 1. Twitter poll by Miriam A. Knoll, MD via Twitter
@MKnoll_MD on May 8, 2020.
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have used the open forum to share experiences, struggles,
and resources during this time. The first thread on this topic
appeared on March 13, before the surge in the United
States; as of June 12, 2020, there were 60 threads and 149
discussions posts related to this topic. The COVID-19
conversations have had 118,238 page-views by 3843 users.
Of note, these statistics count only those visitors who log in
to the forum itself. All ASTRO dmembers receive the
daily digest from the ROhub via email and can read posts
from within their email as well. These discussions helped
inform the expanded COVID-19 resources, FAQs, and up-
dates that appear on the astro.org/covid webpages.
Remote Conferences
The Centers for Disease Control and Prevention recom-
mended limiting face-to-face interactions as the most
effective way to limit the spread of COVID-19.7 These
measures, termed “social distancing,” required meetings to
be held virtually or postponed. For example, the American
Association for Cancer Research annual meeting was held
virtually on April 27 and 28 in lieu of the customary in-
person meeting.8 The meeting reported 61,000 registrants
from 140 countries and meeting content was shared online.
The second portion of the meeting took place June 22 to 24,
2020, with free registration.
In March 2020, the Annual Refresher Course was con-
verted to a virtual meeting, and the ROhub was used to
encourage conversations and as a vehicle to find resources
during the meeting. The Refresher Community had 2248
views as of June 12, 2020.
Similarly, ASCO’s annual meeting took place virtually
from May 29 to 31 for the first time.9 This proved to be a
resounding success as a new record of 42,750 attendees
from 138 countries streamed more than 2.5 million views of
meeting content (and counting). ASTRO’s annual meeting
will also take place virtually in October 2020 “based on our
overwhelming concern for the safety and well-being of our
members, their patients, exhibitors, staff and the families of
all involved.”10 Notably, ESTRO will be one of the first
oncology conferences hosting a hybrid in person and virtual
event in November 2020, which may provide a unique look
into how future meetings can be hosted.
As organizations navigate virtual platforms and online
meetings, engagement with virtual attendees remains key.
How will participating in a virtual meeting be different than
simply watching a YouTube video? Can virtual networking
be facilitated? How will organizations recoup lost revenue
and funding?
Future Opportunities
The challenges faced by radiation oncology during the
coronavirus pandemic were and continue to be abundant.
Social media has facilitated connectivity within our com-
munity by allowing individuals from across the globe to
share information in real time. Should these virtual ties be
maintained when face-to-face interactions resume? If we
value perspectives from outside our 6-foot circle, the
answer is emphatically “yes.”
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